Global prevalence of Ascaris infection in humans (2010-2021): a systematic review and meta-analysis.
Ascaris
Global prevalence
Intensity of infection
Meta-analysis
Systematic review
Journal
Infectious diseases of poverty
ISSN: 2049-9957
Titre abrégé: Infect Dis Poverty
Pays: England
ID NLM: 101606645
Informations de publication
Date de publication:
18 Nov 2022
18 Nov 2022
Historique:
received:
04
08
2022
accepted:
13
10
2022
entrez:
19
11
2022
pubmed:
20
11
2022
medline:
23
11
2022
Statut:
epublish
Résumé
Ascariasis is one of the most important neglected tropical diseases of humans worldwide. The epidemiology of Ascaris infection appears to have changed with improvements in sanitation and mass drug administration, but there is no recent information on prevalence worldwide. Here, we performed a systematic review and meta-analysis to assess the global prevalence of human Ascaris infection from 2010 to 2021. We searched MEDLINE/PubMed, and Scopus databases for studies measuring prevalence of Ascaris infection, published between 1 January 2010 and 1 January 2022. We included studies of the general human population in endemic regions, which used accepted coprodiagnostic methods, and excluded studies of people with occupations with an increased risk or probability of ascariasis and/or specific diseases other than ascariasis. We applied random-effects models to obtain pooled prevalence estimates for six sustainable development goal regions of the world. We extrapolated the prevalence estimates to the global population in 2020, to estimate the number of individuals with Ascaris infection. We conducted multiple subgroup and meta-regression analyses to explore possible sources of heterogeneity, and to assess relationships between prevalence estimates and demographic, socio-economic, geo-climatic factors. Of 11,245 studies screened, we analysed 758 prevalence estimates for a total number of 4,923,876 participants in 616 studies from 81 countries. The global prevalence estimated was 11.01% (95% confidence interval: 10.27-11.78%), with regional prevalences ranging from 28.77% (7.07-57.66%) in Melanesia (Oceania) to 1.39% (1.07-1.74%) in Eastern Asia. We estimated that ~ 732 (682-782) million people harboured Ascaris worldwide in 2021. The infected people in Latin America and the Caribbean region had a higher prevalence of high intensity infection (8.4%, 3.9-14.1%). Prevalence estimates were higher in children, and people in rural communities or in countries or regions with lower income and human development indices. There was a trend for a higher prevalence in regions with increasing mean annual relative humidity, precipitation and environmental temperature. Our findings indicate that, despite a renewed commitment by some communities or authorities to control ascariasis, a substantial portion of the world's human population (> 0.7 billion) is infected with Ascaris. Despite the clinical and socioeconomic importance of ascariasis, many past routine surveys did not assess the intensity of Ascaris infection in people. We propose that the present findings might stimulate the development of customised strategies for the improved control and prevention of Ascaris infection worldwide.
Sections du résumé
BACKGROUND
BACKGROUND
Ascariasis is one of the most important neglected tropical diseases of humans worldwide. The epidemiology of Ascaris infection appears to have changed with improvements in sanitation and mass drug administration, but there is no recent information on prevalence worldwide. Here, we performed a systematic review and meta-analysis to assess the global prevalence of human Ascaris infection from 2010 to 2021.
METHODS
METHODS
We searched MEDLINE/PubMed, and Scopus databases for studies measuring prevalence of Ascaris infection, published between 1 January 2010 and 1 January 2022. We included studies of the general human population in endemic regions, which used accepted coprodiagnostic methods, and excluded studies of people with occupations with an increased risk or probability of ascariasis and/or specific diseases other than ascariasis. We applied random-effects models to obtain pooled prevalence estimates for six sustainable development goal regions of the world. We extrapolated the prevalence estimates to the global population in 2020, to estimate the number of individuals with Ascaris infection. We conducted multiple subgroup and meta-regression analyses to explore possible sources of heterogeneity, and to assess relationships between prevalence estimates and demographic, socio-economic, geo-climatic factors.
RESULTS
RESULTS
Of 11,245 studies screened, we analysed 758 prevalence estimates for a total number of 4,923,876 participants in 616 studies from 81 countries. The global prevalence estimated was 11.01% (95% confidence interval: 10.27-11.78%), with regional prevalences ranging from 28.77% (7.07-57.66%) in Melanesia (Oceania) to 1.39% (1.07-1.74%) in Eastern Asia. We estimated that ~ 732 (682-782) million people harboured Ascaris worldwide in 2021. The infected people in Latin America and the Caribbean region had a higher prevalence of high intensity infection (8.4%, 3.9-14.1%). Prevalence estimates were higher in children, and people in rural communities or in countries or regions with lower income and human development indices. There was a trend for a higher prevalence in regions with increasing mean annual relative humidity, precipitation and environmental temperature.
CONCLUSIONS
CONCLUSIONS
Our findings indicate that, despite a renewed commitment by some communities or authorities to control ascariasis, a substantial portion of the world's human population (> 0.7 billion) is infected with Ascaris. Despite the clinical and socioeconomic importance of ascariasis, many past routine surveys did not assess the intensity of Ascaris infection in people. We propose that the present findings might stimulate the development of customised strategies for the improved control and prevention of Ascaris infection worldwide.
Identifiants
pubmed: 36401308
doi: 10.1186/s40249-022-01038-z
pii: 10.1186/s40249-022-01038-z
pmc: PMC9673379
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
113Informations de copyright
© 2022. The Author(s).
Références
Water Sci Technol. 2010;62(11):2616-24
pubmed: 21099049
Rev Inst Med Trop Sao Paulo. 1972 Nov-Dec;14(6):397-400
pubmed: 4675644
Infect Genet Evol. 2012 Mar;12(2):227-35
pubmed: 22306815
Parasitology. 2018 Nov;145(13):1733-1738
pubmed: 30152296
PLoS Negl Trop Dis. 2013 Apr 11;7(4):e2170
pubmed: 23593529
Adv Parasitol. 2016;94:343-392
pubmed: 27756457
Vet Parasitol. 2010 Aug 4;171(3-4):273-6
pubmed: 20400228
PLoS Negl Trop Dis. 2020 Aug 10;14(8):e0008505
pubmed: 32776942
J Parasitol. 1952 Oct;38(5):445-53
pubmed: 12991137
World Health Organ Tech Rep Ser. 2002;912:i-vi, 1-57, back cover
pubmed: 12592987
PLoS Negl Trop Dis. 2018 Jan 18;12(1):e0006153
pubmed: 29346440
PLoS Negl Trop Dis. 2013 Aug 01;7(8):e2344
pubmed: 23936577
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Nat Protoc. 2010 Mar;5(3):503-15
pubmed: 20203667
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Elife. 2020 Nov 06;9:
pubmed: 33155980
Res Synth Methods. 2016 Mar;7(1):55-79
pubmed: 26332144
Nat Rev Dis Primers. 2020 May 28;6(1):44
pubmed: 32467581
Parasitology. 1995 Feb;110 ( Pt 2):215-9
pubmed: 7885739
Trop Med Int Health. 2017 May;22(5):526-538
pubmed: 28244191
J Clin Pathol. 1970 Sep;23(6):545-6
pubmed: 5529256
J Pediatr Surg. 1996 Jan;31(1):201-4; discussion 204-5
pubmed: 8632280
N Engl J Med. 2013 Apr 25;368(17):1603-12
pubmed: 23614586
J Clin Microbiol. 2005 Mar;43(3):1142-8
pubmed: 15750075
Ann Trop Med Parasitol. 2008 Jun;102(4):283-95
pubmed: 18510809
Parasitology. 2011 Sep;138(11):1406-16
pubmed: 21819640
Parasit Vectors. 2014 Jan 21;7:37
pubmed: 24447578
PLoS Negl Trop Dis. 2017 Nov 6;11(11):e0006022
pubmed: 29108026
Proc Biol Sci. 2007 Nov 7;274(1626):2669-77
pubmed: 17725977
Int J Parasitol. 2021 Dec;51(13-14):1243-1253
pubmed: 34774540
J Infect Dis. 2014 Sep 15;210(6):932-41
pubmed: 24688073
Parasitology. 2009 Oct;136(12):1537-47
pubmed: 19450374
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
J Helminthol. 2012 Jun;86(2):148-55
pubmed: 22423595
Parasitol Today. 1994 Jan;10(1):14-8
pubmed: 15275558
Clin Microbiol Infect. 2020 Jun;26(6):673-683
pubmed: 31972316
Parasit Vectors. 2018 Jan 31;11(1):65
pubmed: 29382360
Lancet. 2017 Jan 21;389(10066):287-297
pubmed: 27979381
PLoS Med. 2010 Nov 09;7(11):e1000367
pubmed: 21085694
Int J Evid Based Healthc. 2015 Sep;13(3):147-53
pubmed: 26317388
Electrophoresis. 2005 Nov;26(22):4317-26
pubmed: 16287175
Parasit Vectors. 2016 Jan 27;9:38
pubmed: 26813411
PLoS Negl Trop Dis. 2019 Aug 9;13(8):e0007580
pubmed: 31398200
Lancet Infect Dis. 2016 Sep;16(9):1076-1084
pubmed: 27236858
Parasitology. 2021 Feb 22;:1-9
pubmed: 33612124
PLoS Negl Trop Dis. 2011 Jun;5(6):e1201
pubmed: 21695104
PLoS Med. 2014 Mar 25;11(3):e1001620
pubmed: 24667810
Infect Genet Evol. 2017 Mar;48:4-9
pubmed: 27939588
Parasit Vectors. 2016 Jan 27;9:31
pubmed: 26813007
Int J Parasitol. 2014 Oct 1;44(11):765-74
pubmed: 24992655